Literature DB >> 25789058

Renal cell carcinoma growing into the renal pelvis and mimicking transitional cell carcinoma: A case report and literature review.

Yifan Li1, Y U Ding2, Duqun Chen1, Zuhu Yu1, Yaoting Gui2, Shangqi Yang2, Yongqing Lai2.   

Abstract

Renal cell carcinoma (RCC) originated from parenchyma and the majority of malignancies originating in the renal pelvis are transitional cell carcinoma (TCC). In the present study, a rare case of RCC growing into the renal pelvis and mimicking TCC in medical imaging is reported. The preoperative differentiation between RCC and TCC is important in order to identify the type of surgical treatment required: Nephrectomy or ureteronephrectomy. The role of ureteroscopy and biopsy is emphasized in the accurate preoperative diagnosis of a renal pelvic mass. Thus, the present study provided fundamental evidence for the pathogenesis of RCC with pelvic extension and challenged the present tumor node metastasis staging system of RCC.

Entities:  

Keywords:  computed tomography; renal cell carcinoma; transitional cell carcinoma; ureteroscopy

Year:  2015        PMID: 25789058      PMCID: PMC4356286          DOI: 10.3892/ol.2015.2898

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


Introduction

Renal cell carcinoma (RCC) is the most common type of kidney parenchymal cancer (1). Malignant tumors of the renal pelvis constitute only 5% of urinary tract neoplasms and ~90% of pelvic cancer cases are transitional cell carcinoma (TCC) (2). Although the majority of malignancies originating in the renal pelvis are TCC, RCC has a tendency to grow into the renal pelvis. The imaging findings of RCC and TCC in the renal pelvis are nonspecific; therefore, preoperative differentiation between RCC and TCC is important in order to identify the type of surgical treatment required: Nephrectomy or ureteronephrectomy (3–5). The present study presents a rare case of an RCC growing into the renal pelvis, in which TCC of the renal pelvis was not able to be distinguished using contrast enhanced computed tomography (CT) or CT urography (CTU). Due to the uncertainty of diagnosis, the present study emphasizes the role of ureteroscopy and biopsy in accurate preoperative diagnosis and the theoretical importance of the present case. Written informed consent was obtained from the patient.

Case report

In April 2013, a 51-year-old male presented to Peking University Shenzhen Hospital (Shenzhen, China) with the chief complaint of a three-year history of repeated dull pain in the right flank and painless gross hematuria for six months. The patient had undergone two previous surgical procedures of extracorporeal shock wave lithotripsy for renal calculus in 1997 and 2009. Physical examination revealed percussion pain over the right kidney region and laboratory analysis identified a marginal increase in alanine aminotransferase (59.8 U/l; normal range, 5.0–40.0 U/l) and creatine (118.5 μmol/l; normal range, 62–115 μmol/l) levels. In addition, an abundance of red blood cells (2,103 cells/μl; normal range, 0–12 cells/μl) was detected upon urinalysis, while urine cytology identified the presence of inflammatory cells but no atypical cells. Intravenous pyelography (IVP) was performed, demonstrating an obstruction to the right renal pelvis and, therefore, no visualization of the later ureter (Fig. 1). A right kidney tumor was suspected based on the results of a dynamic CT scan, which revealed a marginally-contrasted space-occupying lesion in the right kidney. Furthermore, ureteroscopy verified the presence of a solid intraluminal mass (0.6×0.8 cm), spreading into the upper urinary tract in close proximity to the renal pelvis. The renal pelvic masses exhibited wide bases with high central densities and a brittle surface, which bled easily. A ureteroscopic biopsy was performed prior to placing a double-J stent in the right ureter, which was histologically and cytogenetically analyzed to determine a diagnosis of clear-cell RCC. No apparent metastases to the lung, liver, adrenal glands or lymph nodes were observed.
Figure 1

Intravenous pyelogram indicating obstruction of the right renal pelvis by a solid mass (arrows).

Based on the aforementioned results, a diagnosis of a clear-cell RCC of the right kidney was proposed; however, TCC was not be completely excluded. Therefore, to further define the renal pelvic mass, CTU was performed, revealing a 2.0×1.6×3.4 cm papillary right renal pelvic mass without renal parenchymal (Fig. 2A). In the early phase, the tumor presented contrast enhancement and was considered to predominantly consist of TCC (Fig. 2B). Furthermore, the CT value of the tumor was 25 Hounsfield units (HU) in the pre-contrast films and 56 HU in the post-contrast films. However, due to the tentative diagnosis of clear-cell RCC based on the ureteroscopic biopsy, the patient was subjected to open right radical nephrectomy with retention of the ureteral stump. During surgery, frozen section analysis revealed an inflammatory polyp-covered transitional epithelium of mild hyperplasia with blood clots and kidney stones.
Figure 2

(A) Plain computed tomography (CT) scan. White arrows indicate a 2.0×1.6×3.4-cm mass with a central high density in the right renal pelvis. (B) Contrast-enhanced CT scan. Black arrows indicate that the mass was marginally enhanced in the arterial phase.

Macroscopically, the localized tumor originated in the renal calices of the right kidney lower pole, was attached to the renal pelvis by its base and measured 4.0×1.0×0.5 cm. Microscopically, the tumor was composed of atypical epithelioid cells with a wide distribution, with interstitial edema and infiltration of the focal lymphoid tissue; however, no invasion of the ureteral wall was observed. Immunohistochemically, the tumor exhibited diffuse positive staining for vimentin and P504S, while it was only focally and weakly positive for cytokeratin (CK) 7, cluster of differentiation 10 and Ki-67. In addition, immunostaining for CK20, uroplakin, kidney-specific cadherin and prostate-specific antigen was negative. These findings were in accordance with a diagnosis of RCC; however, it remains unclear whether the tumor was a clear-cell or papillary RCC as the patient declined to undergo further assessment. No malignancy was observed in the local renal pelvic or ureteral mucosa. The patient was discharged nine days after surgery, following an uncomplicated postsurgical recovery. No evidence of recurrence or residual disease was detected on CT scans during the nine-month follow-up period.

Discussion

The present study reported the challenging diagnosis of a marginally-enhanced renal pelvic mass that was identified using dynamic CT/CTU. Histological analysis revealed a clear-cell RCC with renal pelvic invasion, which is a rare carcinoma reported only in a small number of cases in the English literature (Table I) (3–9). Due to inadequate preoperative diagnosis of TCC, nephroureterectomy has been performed in a number of previous cases (3,5). However, nephroureterectomy including cuff resection of the bladder wall was performed in one case since frozen section analysis was unable to exclude TCC (8). RCC with renal pelvic extension was possibly mistaken for TCC only based on CT findings or frozen section analysis. Therefore, the results of various diagnostic approaches, particularly contrast enhanced CT/CTU, ureteroscopy and biopsy, in the preoperative diagnosis of such renal pelvic masses should be compared and assessed.
Table I

Reported cases of RCC growing into the renal pelvis.

CaseReference, yearAge (years)/genderCT descriptionUreteroscopy or cystoscopy/biopsyPreoperative diagnosisHistological diagnosis
1Munechika et al (3), 199022/MCalcified tumor in the lower pole of the right kidney, renal pelvis and proximal ureterNot performedTCCMixed-type RCC
2Chen et al (6), 199662/FTumor in the right kidney and renal pelvisNot performedUncertainRCC
3Gulati et al (7), 200767/MIrregular kidney mass and bladder massCystoscopy revealed a 5-cm mass emanating from the left ureteral orifice/RCCRCCClear-cell RCC
4Fujita et al (8), 201143/MEnhanced tumor in the left kidney, renal pelvis, ureter and bladderCystoscopy revealed no obvious tumorous lesion/not performedRCCClear-cell RCC
5Kitazono et al (4), 201164/MEnhanced mass in the left kidney upper pole, renal pelvis and ureterNot performedUncertainClear-cell RCC
6Kitazono et al (4), 201177/FLarge mass in the right kidney invaded the pelvicaliceal systemUreteroscopy confirmed pelvicaliceal involvement/not performedUncertainClear-cell RCC
7Jeong and Kim (5), 201258/FEnhanced left renal pelvic massCystoscopy was negative for TCC/not performedTCCClear-cell RCC
8Kakutani et al (9), 201351/FContrasted tumor in the left, kidney renal pelvis, ureter and bladderCystoscopy revealed a tumor emanating from the left ureteral orifice/not performedRenal pelvic tumorClear-cell RCC
9Present study, 201551/MEnhanced right renal pelvic massUreteroscopy confirmed a renal pelvic mass/clear cell RCCClear-cell RCCRCC

RCC, renal cell carcinoma; M, male; F, female; CT, computed tomography; TCC, transitional cell carcinoma.

Dynamic CT/CTU has been increasingly performed as an alternative to the traditional method (IVP) for the diagnosis of upper tract lesions, due to its high diagnostic accuracy and favorable comparisons with other imaging techniques (10). However, the principal limitation of CTU is false-positive diagnosis; thus, a renal pelvic mass diagnosed with CTU should be biopsied (guided by ureteroscopy) for histopathological confirmation prior to proceeding with the surgical procedure (10). An enhanced mass, which may indicate a non-opaque pyelolith, blood clot, lymphoma or, less commonly, RCC and metastasis to the kidney with renal pelvic invasion, has been identified in patients exhibiting painless hematuria using CT/CTU (2,4). Dynamic CT images and HU values or angiography with contrast injection may provide a comprehensive view and vascular indications of the pelvic mass. By contrast, three-dimensional CTU or magnetic resonance imaging aid in delineating the precise location of the renal mass and its association with the collecting system and renal vessels (2). However, occasionally the distinction between TCC with renal invasion and RCC with renal pelvic extension is difficult, since imaging findings of hypovascular RCC demonstrate location, shape and enhancement that are indistinguishable from TCC. Although significant differences in multiphase CT attenuation have been reported between RCC and TCC, the application of these results may be limited to facilitating the differential diagnosis when the diagnosis is uncertain and avoiding biopsy (11). In cases of uncertain diagnosis, the present study advocates that appropriate ureteroscopy and biopsy should be performed to provide crucial histopathological information as the most important evidence. In certain cases, ureteroscopy cannot be performed due to urethral edema, stricture or obstruction; therefore, frozen section analysis is recommended to determine any required changes to the surgical strategy (4,5,9). RCC with renal pelvic invasion is hypothesized to occur due to the hollow structure of the renal pelvis. Invasion is easier in the renal pelvis compared with the renal parenchyma when localized RCC originates in the marginal parenchyma surrounding the renal pelvis or when RCC invades the entire kidney. In the present case, RCC did not invade the normal urothelium of the renal pelvis; however, in a number of previous cases, the tumors had expanded into the ureter and bladder (7,9). Therefore, the present study provides fundamental evidence for the following theory: Implantation and/or invasion of the urothelial mucosa followed by intraluminal expansive growth results in the pathogenesis of RCC with pelvic extension (9). Previous cases reporting RCC growth along the urinary tract support the following mechanism of RCC metastasis: Tumor cells may metastasize via intraluminal transit down the urinary tract and invade the distal ureter or bladder (7,9). Although these previous cases provide evidence of a possible mechanism of RCC growth, they also challenge the present tumor node metastasis (TNM) staging system. The case reported in the present study indicates that RCC with invasion of the urinary collecting system should be included in the present TNM staging system. However, the inclusion of the urinary collecting system invasion of RCC in the TNM staging system remains controversial (12,13). In conclusion, in this study, a rare case of RCC growing into the renal pelvis was presented and the role of ureteroscopy and biopsy in accurate preoperative diagnosis was highlighted. The present study provided fundamental evidence for the pathogenesis of RCC with pelvic extension and challenged the present TNM staging system of RCC. However, whether the invasion of the urinary collecting system is an independent prognostic factor in RCC remains controversial and thus, further studies are required.
  13 in total

1.  CT of unusual renal masses invading the pelvicaliceal system: potential mimics of upper tract transitional cell carcinoma.

Authors:  Mary T Kitazono; Fergus V Coakley; David M Naeger; Benjamin M Yeh; Bonnie N Joe; Aliya Qayyum
Journal:  Clin Imaging       Date:  2011 Jan-Feb       Impact factor: 1.605

2.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

3.  Urinary collecting system invasion is no independent prognostic factor in renal cell carcinoma.

Authors:  Sandra Waalkes; Axel S Merseburger; Thomas R W Herrmann; Mario W Kramer; Gerd Wegener; Julia Rustemeier; Rainer Hofmann; Markus A Kuczyk; Andres J Schrader
Journal:  World J Urol       Date:  2010-03-18       Impact factor: 4.226

4.  Is it transitional cell carcinoma or renal cell carcinoma on computed tomography image?

Authors:  Young Beom Jeong; Hyung Jin Kim
Journal:  Urology       Date:  2011-12-22       Impact factor: 2.649

Review 5.  CT urography for hematuria.

Authors:  Nigel C Cowan
Journal:  Nat Rev Urol       Date:  2012-03-13       Impact factor: 14.432

6.  Renal cell carcinoma with renal pelvic extension simulating transitional cell carcinoma: a case report.

Authors:  W C Chen; Y H Lee; J K Huang
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1996-08

Review 7.  The renal sinus: pathologic spectrum and multimodality imaging approach.

Authors:  Sung Eun Rha; Jae Young Byun; Seung Eun Jung; Soon Nam Oh; Yeong-Jin Choi; Ahwon Lee; Jae Mun Lee
Journal:  Radiographics       Date:  2004-10       Impact factor: 5.333

8.  Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.

Authors:  Grégory Verhoest; Raffi Avakian; Karim Bensalah; Rodolphe Thuret; Vincenzo Ficarra; Walter Artibani; Jacques Tostain; François Guille; Lucas Cindolo; Alexandre De La Taille; Claude-Clément Abbou; Laurent Salomon; Nathalie Rioux-Leclercq; Jean-Jacques Patard
Journal:  J Urol       Date:  2009-07-17       Impact factor: 7.450

9.  Renal cell carcinoma with a tumor thrombus in the ureter: a case report.

Authors:  Osamu Fujita; Koichiro Wada; Tomoya Yamasaki; Daisuke Manabe; Katsuji Takeda; Satoko Nakamura
Journal:  BMC Urol       Date:  2011-08-01       Impact factor: 2.264

10.  Renal cell carcinoma with intraluminal spread of the entire upper urinary tract.

Authors:  Shigenori Kakutani; Haruki Kume; Yoshikazu Hirano; Toshihiko Wakita; Yukio Homma
Journal:  Case Rep Med       Date:  2013-05-07
View more
  5 in total

Review 1.  [Clinical and pathological features of renal cell carcinoma with urinary tract tumor thrombus: 6 cases report and literature review].

Authors:  Y Tian; X Y Cheng; H Y He; G L Wang; L L Ma
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-18

2.  Intrarenal urothelial cancers confused as infiltrative renal masses: Report of 22 cases and literature review.

Authors:  Xiaobo Ding; Xiaobo Ma; Yatao Jia; Hongfei Li; Yanbo Wang
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

3.  Preoperative Lymphocyte-Monocyte Ratio Ameliorates the Accuracy of Differential Diagnosis in Non-Metastatic Infiltrative Renal Masses.

Authors:  Jang Hee Han; Young Eun Yoon; Sook Young Kim; Young In Cho; Koon Ho Rha; Young Deuk Choi; Woong Kyu Han
Journal:  Yonsei Med J       Date:  2017-03       Impact factor: 2.759

4.  Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China.

Authors:  Ning Liu; Feng Qu; Qiancheng Shi; Wenyuan Zhuang; Wenliang Ma; Zhenhao Yang; Jing Sun; Wei Xu; Lihua Zhang; Ruipeng Jia; Linfeng Xu; Xiaozhi Zhao; Xiaogong Li; Gutian Zhang; Hongqian Guo; Dongmei Li; Weidong Gan
Journal:  Ann Surg Oncol       Date:  2020-07-06       Impact factor: 5.344

5.  MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K/AKT signaling pathway by inhibiting CAV1.

Authors:  Ning Han; Hai Li; Hui Wang
Journal:  Cell Adh Migr       Date:  2020-12       Impact factor: 3.405

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.